Diastolic blood pressure levels and ischemic stroke incidence in older adults with white matter lesions

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 66 A, Issue 1, 2011, Pages 74-81

  Reshef, Shoshana ^a   Fried, Linda ^b   Beauchamp, Norman ^c   Scharfstein, Daniel ^a   Reshef, Daniel ^d   Goodman, Steven ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b Columbia University ^*  (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d Drug Safety Risk Management   (United States)

Author keywords

Blood pressure; Cardiovascular Health Study; Ischemic stroke; White matter lesions

Indexed keywords

AGED; ARTICLE; BRAIN; BRAIN CIRCULATION; BRAIN ISCHEMIA; DIASTOLE; FEMALE; HUMAN; INCIDENCE; MALE; MULTIVARIATE ANALYSIS; PATHOLOGY; STROKE;

AGED; AGED, 80 AND OVER; BRAIN; BRAIN ISCHEMIA; CEREBROVASCULAR CIRCULATION; DIASTOLE; FEMALE; HUMANS; INCIDENCE; MALE; MULTIVARIATE ANALYSIS; STROKE;

EID: 79951589855     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glq166     Document Type: Article

References (43)

1. Sudlow C L M, Warlow CP. Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. Stroke. 2003;28:491-499.
2. Forette F, Lechowski L, Rigaud AS, Seux ML, Dessi F, Forette B. Does the benefit of antihypertensive treatment outweigh the risk in very elderly hypertensive patients? J Hypertens Suppl. 2000;18: S9-S12. (Pubitemid 30663914)
3. Voko Z, Bots ML, Hofman A, Koudstaal PJ, Witteman JC, Breteler MM. J-shaped relation between blood pressure and stroke in treated hypertensives. Hypertension. 1999;34:1181-1185. (Pubitemid 30002379)
4. Mattila K, Haavisto M, Rajala S, Heikinheimo R. Blood pressure and five year survival in the very old. Br Med J (Clin Res Ed). 1988;296:887-889. (Pubitemid 18081872)
5. Meyer J, Lechner H, Reivich M, Ott EO. Four Year Longitudinal Prospective Analysis of Age-Related Changes in Cerebral Blood Flow Measured in Normal Healthy and Risk Factored Volunteers; Amsterdam, The Netherlands: Excerpta Medica; 1983:15-21.
6. Pickering TG. The clinical significance of diurnal blood pressure variations. Dippers and nondippers. Circulation. 1990;81:700-702. (Pubitemid 20055982)
7. Kario K, Pickering TG, Matsuo T, Hoshide S, Schwartz JE, Shimada K. Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension. 2001;38:852-857. (Pubitemid 34258682)
8. Kario K, Shimada K, Pickering TG. Abnormal nocturnal blood pressure falls in elderly hypertension: clinical significance and determinants. J Cardiovasc Pharmacol. 2003;41(suppl 1): S61-S66. (Pubitemid 36015035)
9. Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: a review. Stroke. 1997;28:652-659. (Pubitemid 27118393)
10. Kawamura J, Terayama Y, Takashima S, et al. Leuko-araiosis and cerebral perfusion in normal aging. Exp Aging Res. 1993;19:225-240. (Pubitemid 23308506)
11. Markus HS, Lythgoe DJ, Ostegaard L, O'Sullivan M, Williams SC. Reduced cerebral blood flow in white matter in ischaemic leukoaraiosis demonstrated using quantitative exogenous contrast based perfusion MRI. J Neurol Neurosurg Psychiatry. 2000;69:48-53. (Pubitemid 30410414)
12. Longstreth WT Jr., Manolio TA, Arnold A, et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke. 1996;27:1274-1282. (Pubitemid 26286152)
13. Meyer JS, Rauch G, Rauch RA, Haque A. Risk factors for cerebral hypoperfusion, mild cognitive impairment, and dementia. Neurobiol Aging. 2000;21:161-169. (Pubitemid 30387075)
14. Bhadelia RA, Anderson M, Polak JF, et al. Prevalence and associations of MRI-demonstrated brain infarcts in elderly subjects with a history of transient ischemic attack. The Cardiovascular Health Study. Stroke. 1999;30:383-388. (Pubitemid 29071805)
15. Kuller LH, Longstreth WT Jr., Arnold AM, Bernick C, Bryan RN, Beauchamp NJ Jr. White matter hyperintensity on cranial magnetic resonance imaging: a predictor of stroke. Stroke. 2004;35:1821-1825. (Pubitemid 38971858)
16. Meyer JS, Kawamura J, Terayama Y. White matter lesions in the elderly. J Neurol Sci. 1992;110:1-7.
17. Cruickshank J. The J-curve in hypertension. Curr Cardiol Rep. 2003;5:441-452. (Pubitemid 38906891)
18. Cruickshank JM. Antihypertensive treatment and the J-curve. Cardiovasc Drugs Ther. 2000;14:373-379. (Pubitemid 30663719)
19. Farnett L, Mulrow CD, Linn WD, Lucey CR, Tuley MR. The J-curve phenomenon and the treatment of hypertension. Is there a point beyond which pressure reduction is dangerous? JAMA. 1991;265:489-495.
20. Samuelsson OG, Wilhelmsen LW, Pennert KM, Wedel H, Berglund GL. The J-shaped relationship between coronary heart disease and achieved blood pressure level in treated hypertension: further analyses of 12 years of follow-up of treated hypertensives in the Primary Prevention Trial in Gothenburg, Sweden. J Hypertens. 1990;8:547-555. (Pubitemid 20301431)
21. Cruickshank JM, Thorp JM, Zacharias FJ. Benefits and potential harm of lowering high blood pressure. Lancet. 1987;1:581-584.
22. Somes GW, Pahor M, Shorr RI, Cushman WC, Applegate WB. The role of diastolic blood pressure when treating isolated systolic hypertension. Arch Intern Med. 1999;159:2004-2009. (Pubitemid 29453587)
23. Voko Z, Koudstaal P, Bots M, Hofman A, Breteler M. Aspirin use and risk of stroke in the elderly: the rotterdam study. Neuroepidemiology. 2001;20:40-44. (Pubitemid 32171137)
24. Vermeer SE, Hollander M, van Dijk EJ, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke. 2003;34:1126-1129. (Pubitemid 36547501)
25. Fried LP, Borhani NO, Enright P, et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol. 1991;1:263-276.
26. Manolio TA, Kronmal RA, Burke GL, et al. Magnetic resonance abnormalities and cardiovascular disease in older adults. The Cardiovascular Health Study. Stroke. 1994;25:318-327. (Pubitemid 24047252)
27. Price TR, Psaty B, O'Leary D, Burke G, Gardin J. Assessment of cerebrovascular disease in the Cardiovascular Health Study. Ann Epidemiol. 1993;3:504-507. (Pubitemid 23339588)
28. STATA Corporation. STATA Base Reference Manual. Release 8.0[2]. College Station, TX: Stata Press; 2003.
29. Strandgaard S, Paulson OB. Cerebrovascular damage in hypertension. J Cardiovasc Risk. 1995;2:34-39.
30. Strandgaard S, Paulson OB. Cerebral blood flow in untreated and treated hypertension. Neth J Med. 1995;47:180-184.
31. Meyer JS, Terayama Y, Takashima S. Cerebral circulation in the elderly. Cerebrovasc Brain Metab Rev. 1993;5:122-146.
32. Caplan LR, Hennerici M. Impaired clearance of emboli (washout) is an important link between hypoperfusion, embolism, and ischemic stroke. Arch Neurol. 1998;55:1475-1482. (Pubitemid 28525511)
33. Chimowitz MI, Furlan AJ, Jones SC, et al. Transcranial Doppler assessment of cerebral perfusion reserve in patients with carotid occlusive disease and no evidence of cerebral infarction. Neurology. 1993;43:353-357. (Pubitemid 23060269)
34. Kannel WB, Wilson PW, Nam BH, D'Agostino RB, Li J. A likely explanation for the J-curve of blood pressure cardiovascular risk. Am J Cardiol. 2004;94:380-384. (Pubitemid 38962714)
35. Kannel WB, D'Agostino RB, Silbershatz H. Blood pressure and cardiovascular morbidity and mortality rates in the elderly. Am Heart J. 1997;134:758-763. (Pubitemid 27465073)
36. Kaplan NM. Kaplan's Clinical Hypertension. Philadelphia: Lippincott Williams & Wilkins; 2002.
37. Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive bloodpressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet. 1998;351:1755-1762. (Pubitemid 28269185)
38. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991;265:3255-3264.
39. Hansson L. How far should we lower blood pressure in the elderly. Cardiovasc Drugs Ther. 2001;15:275-279. (Pubitemid 33010612)
40. Kaplan N. J-curve not burned off by HOT study. Hypertension Optimal Treatment. Lancet. 1998;351:1748-1749. (Pubitemid 28269179)
41. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 Report. JAMA. 2003;289:2560-2572. (Pubitemid 37430158)
42. Kaplan NM. What is goal blood pressure for the treatment of hypertension? Arch Intern Med. 2001;161:1480-1482. (Pubitemid 32679559)
43. Hansson L. Antihypertensive treatment: does the J-curve exist? Cardiovasc Drugs Ther. 2000;14:367-372. (Pubitemid 30663718)